Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure

INTRODUCTION: High cut-off dialysis, increasingly used in multiple myeloma patients, is susceptible to influence anticancer drug elimination. We report about lenalidomide disposition in a patient on high cut-off dialysis for renal failure secondary to myeloma cast nephropathy. METHODS: The patient r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Chemother Pharmacol
Autors principals: Dao, Kim, Lu, Yimin, Peer, Cody J., Figg, William D., Stadelmann, Raphael, Burnier, Michel, Buclin, Thierry, Kissling, Sebastien
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410697/
https://ncbi.nlm.nih.gov/pubmed/27988790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3219-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars